Drugs / Astengenal
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01260103 | Dec 2011 → Dec 2016 | optic nerve glioma | Burzynski Research Institute | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Astengenal | “Astengenal (A10)” NCT01260103 ↗ |
| Known as | A10 | “Astengenal (A10)” NCT01260103 ↗ |
| Known as | Astengenal (A10) | “Astengenal (A10)” NCT01260103 ↗ |